| 1. |
Hanahan, D., and Weinberg, R.A. (2000) The hallmarks of cancer. Cell
100, 57–70.
|
| |
| 2. |
Hengartner, M.O. (2000) The biochemistry of apoptosis. Nature
407, 770–776.
|
| |
| 3. |
Zhang, X.D., Borrow, J.M., Zhang, X.Y., Nguyen, T., and Hersey, P. (2003) Activation of ERK1/2 protects melanoma cells from
TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Oncogene
22, 2869–2881.
|
| |
| 4. |
Wan, W.H., Fortuna, M.B., and Furmanski, P.A. (1987) rapid and efficient method for testing immunohistochemical reactivity
of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods
103, 121–129.
|
| |
| 5. |
Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M.J., Sauter,
G., and Kallioniemi, O.P. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med
4, 844–847.
|
| |
| 6. |
Bova, G.S., Parmigiani, G., Epstein, J.I., Wheeler, T., Mucci, N.R., and Rubin, M.A. (2001) Web-based tissue microarray image
data analysis: initial validation testing through prostate cancer Gleason grading. Hum Pathol
32, 417–427.
|
| |
| 7. |
Camp, R.L., Charette, L.A., and Rimm, D.L. (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest
80, 1943–1949.
|
| |
| 8. |
Hoos, A., Urist, M.J., Stojadinovic, A., Mastorides, S., Dudas, M.E., Leung, D.H., Kuo, D., Brennan, M.F., Lewis, J.J., and
Cordon-Cardo, C. (2001) Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example
of human fibroblastic tumors. Am J Pathol
158, 1245–1251.
|
| |
| 9. |
Giltnane, J.M., and Rimm, D.L. (2004) Technology insight: identification of biomarkers with tissue microarray technology.
Nat Clin Pract Oncol
1, 104–111.
|
| |
| 10. |
DiVito, K.A., Charette, L.A., Rimm, D.L., and Camp, R.L. (2004) Long-term preservation of antigenicity on tissue microarrays.
Lab Invest
84, 1071–1078.
|
| |
| 11. |
Kluger, H.M., DiVito, K., Berger, A.J., Halaban, R., Ariyan, S., Camp, R.L., and Rimm, D.L. (2004) Her2/neu is not a commonly
expressed therapeutic target in melanoma. Melanoma Res
14, 207–210.
|
| |
| 12. |
Divito, K.A., Berger, A.J., Camp, R.L., Dolled-Filhart, M., Rimm, D.L., and Kluger, H.M. (2004) Automated quantitative analysis
of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma. Cancer Res. 64, 8773–8777.
|
| |
| 13. |
McCarthy, M.M., Sznol, M., DiVito, K.A., Camp, R.L., Rimm, D.L., and Kluger, H.M. (2005) Evaluating the expression and prognostic
value of TRAIL-R1 and TRAIL-R2 in breast cancer. Clin Cancer Res
11, 5188–5194.
|
| |
| 14. |
Camp, R.L., Chung, G.G., and Rimm, D.L. (2002) Automated subcellular localization and quantification of protein expression
in tissue microarrays. Nat Med
8, 1323–1327.
|
| |
| 15. |
Camp, R.L., Dolled-Filhart, M., King, B.L., and Rimm, D.L. (2003) Quantitative analysis of breast cancer tissue microarrays
shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res
63, 1445–1448.
|
| |
| 16. |
Koscielny, S., Terrier, P., Spielmann, M., and Delarue, J.C. (1998) Prognostic importance of low c-erbB2 expression in breast
tumors. J Natl Cancer Inst
90, 712.
|
| |
| 17. |
Rubin, M.A., Zerkowski, M.P., Camp, R.L., Kuefer, R., Hofer, M.D., Chinnaiyan, A.M., and Rimm, D.L. (2004) Quantitative determination
of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a
novel paradigm for automated and continuous biomarker measurements. Am J Pathol
164, 831–840.
|
| |
| 18. |
Camp, R.L., Chung, G.G., and Rimm, D.L. (2002) Automated subcellular localization and quantification of protein expression
in tissue microarrays. Nat Med
11, 1323–1327.
|
| |
Loading...